Amyotrophic lateral sclerosis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Oct 2026Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Revalesio Corporation — PHASE2

TrialNOT YET RECRUITING
Jun 2026This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling

Gipfel Life Sciences GmbH — PHASE2, PHASE3

TrialNOT YET RECRUITING
Jun 2026Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?

Trustees of Dartmouth College — NA

TrialNOT YET RECRUITING
Apr 2026Invasive Home Ventilation in Denmark

Rigshospitalet, Denmark

TrialNOT YET RECRUITING
Apr 2026Characterization of Platelet Molecular Profiles in ALS for the Identification of Specific Diagnostic Biomarkers - A Pilot Study

University Hospital, Tours

TrialNOT YET RECRUITING
Apr 2026Virtual Reality for Anxiety Management in Persons With Amyotrophic Lateral Sclerosis

Horizon Health Network — NA

TrialNOT YET RECRUITING
Apr 2026Digital Speech Markers for Monitoring ALS in Spanish Speakers

Nova Southeastern University

TrialNOT YET RECRUITING
Mar 2026A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)

Biogen

TrialNOT YET RECRUITING
Mar 2026Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis

Royal Brompton & Harefield NHS Foundation Trust

TrialRECRUITING
Mar 2026Healey ALS MyMatch Common Screening Protocol

Massachusetts General Hospital

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

30 programs

FINANCIAL LANDSCAPE SUMMARY

30

Total programs

22

Open now

$40K

Available/year

6

Foundation grants

3

Copay cards

21

Travel grants

Foundation Grants6

The Assistance Fund — Amyotrophic lateral sclerosis

The Assistance Fund

OpenContact for detailsApply ↗

HealthWell Foundation — Amyotrophic lateral sclerosis

HealthWell Foundation

OpenContact for detailsApply ↗

PAN Foundation — Amyotrophic lateral sclerosis

PAN Foundation

OpenContact for detailsApply ↗

Good Days — Amyotrophic lateral sclerosis

Good Days

OpenContact for detailsApply ↗

NORD Patient Assistance — Amyotrophic lateral sclerosis

NORD Patient Assistance

OpenContact for detailsApply ↗

Patient Advocate Foundation — Amyotrophic lateral sclerosis

Patient Advocate Foundation

OpenContact for detailsApply ↗

Copay Assistance3

Edaravone

Mitsubishi Tanabe

OpenContact for detailsApply ↗

QALSODY

Biogen

OpenContact for detailsApply ↗

Riluzole

Sanofi

OpenContact for detailsApply ↗

Travel Grants21

Amyotrophic Lateral Sclerosis Financial Assistance Program

Contact for detailsApply ↗

Chiesi Total Care Myalept Patient Support Services

Chiesi

Contact for detailsApply ↗

HealthWell Foundation Financial Assistance

HealthWell Foundation

OpenContact for detailsApply ↗

HealthWell Foundation Financial Assistance Resources

HealthWell Foundation

OpenContact for detailsApply ↗

Ipsen Cares Patient Assistance Program

OpenContact for detailsApply ↗

MTPA Patient Assistance Program

OpenContact for detailsApply ↗

NORD Travel Assistance for Clinical Research and ALS Clinical Trials

NORD

Contact for detailsApply ↗

Pfizer Dermatology Patient Access Financial Support

Pfizer

OpenUp to $15K/yrApply ↗

Pfizer enCompass Co-Pay Assistance Program

Pfizer

OpenContact for detailsApply ↗

Pfizer enCompass Reimbursement Support and Patient Support

Pfizer

OpenContact for detailsApply ↗

Pfizer Oncology Together

Pfizer

Contact for detailsApply ↗

Pfizer Oncology Together Co-Pay Savings Program

Pfizer

Contact for detailsApply ↗

Pfizer Oncology Together Financial Assistance

Pfizer

OpenUp to $25K/yrApply ↗

Pfizer Patient Assistance Program

Pfizer

Contact for detailsApply ↗

Pfizer RxPathways

Pfizer

OpenContact for detailsApply ↗

Pfizer RxPathways Patient Support Hub

Pfizer

OpenContact for detailsApply ↗

Pfizer RxPathways Support Hub

Pfizer

OpenContact for detailsApply ↗

Pfizer RxPathways Support Hub Programs

Pfizer

OpenContact for detailsApply ↗

Pfizer RxPathways Treatment-Specific Patient Support Hubs

Pfizer

Contact for detailsApply ↗

RADICAVA ORS (edaravone) VA Financial Assistance and Support

Mitsubishi Tanabe Pharma America

Contact for detailsApply ↗

The Hoffman ALS Financial Assistance Program

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Rilutek

(Riluzole)Orphan drug

Rhone-Poulenc Rorer Pharmaceuticals, Inc.

View full treatment details on disease page →

Clinical Trial Landscape

134 active trials
4Phase 3
2Phase 4
13Phase 2
14Phase 1
37N/A
53Unknown
3PHASE2, PHASE3
3EARLY_PHASE1
5PHASE1, PHASE2
134Total recruiting
Search clinical trials for Amyotrophic lateral sclerosis

Recent News & Research

No recent news articles indexed yet for Amyotrophic lateral sclerosis.
Search PubMed for Amyotrophic lateral sclerosis

Browse all Amyotrophic lateral sclerosis news →

Specialist Network

Top 6 by expertise

View all Amyotrophic lateral sclerosis specialists →

Quick Actions